Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Shares Outstanding (Diluted Average) (2021 - 2023)

Historic Shares Outstanding (Diluted Average) for Candel Therapeutics (CADL) over the last 3 years, with Q3 2023 value amounting to $28.9 million.

  • Candel Therapeutics' Shares Outstanding (Diluted Average) rose 9.66% to $28.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $28.9 million, marking a year-over-year increase of 9.66%. This contributed to the annual value of $28.8 million for FY2022, which is 5272.3% up from last year.
  • As of Q3 2023, Candel Therapeutics' Shares Outstanding (Diluted Average) stood at $28.9 million, which was up 9.66% from $28.9 million recorded in Q2 2023.
  • In the past 5 years, Candel Therapeutics' Shares Outstanding (Diluted Average) registered a high of $28.9 million during Q1 2023, and its lowest value of $11.7 million during Q2 2021.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $28.8 million (2022), whereas its average is $25.6 million.
  • In the last 5 years, Candel Therapeutics' Shares Outstanding (Diluted Average) surged by 14580.99% in 2022 and then grew by 9.66% in 2023.
  • Over the past 3 years, Candel Therapeutics' Shares Outstanding (Diluted Average) (Quarter) stood at $18.9 million in 2021, then soared by 52.72% to $28.8 million in 2022, then increased by 0.33% to $28.9 million in 2023.
  • Its Shares Outstanding (Diluted Average) was $28.9 million in Q3 2023, compared to $28.9 million in Q2 2023 and $28.9 million in Q1 2023.